ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Andere Sprachen Zylox-Tonbridge Medical Technology Co., Ltd.

Aktien

A3CS7H

CNE100004JD2

2190

Markt geschlossen - Hong Kong S.E. Andere Börsenplätze 10:08:16 24.04.2024			% 5 Tage	% 1. Jan.
10.5 ^HKD	+3.96%		+10.53%	-15.59%

22.03.	Zylox-Tonbridge schrumpft Verlust im Geschäftsjahr 2023 um 31%	MT
21.03.	Zylox-Tonbridge Medical Technology Co., Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023	22.03.
Zylox-Tonbridge Medical Technology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	21.03.
Avinger in Equity Funding Partnership With Chinese Medical Device Firm, Unveils Debt-Terms Extension; Shares Rise Premarket	07.03.
Zylox-Tonbridge Enters Licensing, Investment Contracts with American Innovative Medical Device Maker	07.03.
Avinger, Inc. Announces New Strategic Partnership with Zylox-Tonbridge Medical Technology Co., Ltd	07.03.
Avinger, Inc. announced that it expects to receive $15 million in funding from Zylox-Tonbridge Medical Technology Co., Ltd.	04.03.
Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the UAE	21.02.
China Grants Marketing Approval to Zylox-Tonbridge's Peripheral Venous Stent System; Shares Fall 7%	22.01.
Zylox-Tonbridge Medical Technology Co., Ltd Receives Marketing Approval from National Medical Products Administration Grants Marketing for Zylox® Penguin Peripheral Venous Stent System	22.01.
Zylox-Tonbridge Medical Technology Co., Ltd. Announces National Medical Products Administration Grants Marketing Approval for Zylox Phoenix Peripheral Detachable Fibrous Coil Embolization System	29.12.
Zylox Tonbridge Secures Chinese Marketing Approval for Arterial Embolization Device	29.12.
Zylox-Tonbridge Completes Patient Enrolment for Post-Marketing Clinical Trial of Stent System in EU	21.12.
Zylox-Tonbridge Medical Technology Co., Ltd. Completes Enrollment of All 100 Patients in the Multi-Center Clinical Trial in Germany	20.12.
Zylox-Tonbridge Medical Technology Co., Ltd. Receives Official Marketing Approval	11.12.
China Grants Marketing Approval to Zylox-Tonbridge's Balloon Catheter	11.12.
China Gives Marketing Approval for Zylox-Tonbridge's Blood Vessel Distal Support Catheter	06.12.
Zylox-Tonbridge Medical Technology Co., Ltd. Announces Change of Address of Registered Office	07.11.
Zylox-Tonbridge Medical Technology Co., Ltd. commences an Equity Buyback Plan for 32,461,974 shares, representing 10% of its issued share capital, under the authorization approved on June 6, 2023.	07.11.
Zylox-Tonbridge Trustee Buys About 1.1 Million Shares Under Share Award, Trust Scheme; Shares Jump 5%	06.11.
Zylox-Tonbridge Medical Buys Back 1.1 Million Shares	13.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Zylox-Tonbridge Medical Technology Co., Ltd.

Aktien

A3CS7H

CNE100004JD2

2190

Andere Sprachen

Filter